[NEJM] Trial of Prasinezumab in Early-Stage Parkinson¡¯s Disease

and618and Post time 2022-8-12 16:12:12 | Show all posts |Read mode
Reward10points

journal£ºNew England Journal of Medicine

Authors£ºGennaro Pagano; Kirsten I. Taylor; Judith Anzures-Cabrera; Maddalena Marchesi; Tanya Simuni; Kenneth Marek; Ronald B. Postuma; Nicola Pavese; Fabrizio Stocchi; Jean-Philippe Azulay; Brit Mollenhauer; Lydia L¨®pez-Manzanares; David S. Russell; James T. Boyd; Anthony P. Nicholas; Mar¨ªa R. Luquin; Robert A. Hauser; Thomas Gasser; Werner Poewe; Benedicte Ricci; Anne Boulay; Annamarie Vogt; Frank G. Boess; Juergen Dukart; Giulia D¡¯Urso; Rebecca Finch; Stefano Zanigni; Annabelle Monnet; Nathalie Pross; Andrea Hahn; Hanno Svoboda; Markus Britschgi; Florian Lipsmeier; Ekaterina Volkova-Volkmar; Michael Lindemann; Sebastian Dziadek; Stefan Holiga; Daria Rukina; Thomas Kustermann; Geoffrey A. Kerchner; Paulo Fontoura; Daniel Umbricht; Rachelle Doody; Tania Nikolcheva; Azad Bonni

Published date£º2022-8-4

DOI£º10.1056/nejmoa2202867

Article link£ºhttp://dx.doi.org/10.1056/nejmoa2202867

Article Source£ºMassachusetts Medical Society¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Report

Reply all1 Show all posts
David Post time 2022-8-12 16:12:13 | Show all posts
Please adopt

nejmoa2202867.pdf

601.72 KB, Downloads: 1

Reply

Use magic Report

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list